Compare ArcelorMittal SA (MT) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Teladoc Health Inc — how do they compare? ArcelorMittal SA trades at $64.3 (market cap $45.70B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: ArcelorMittal SA is far larger — about 45.2× Teladoc Health Inc's market cap, and ArcelorMittal SA pays a 0.98% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold ArcelorMittal SA for 36 Days and Teladoc Health Inc for 39 Days on average.
| MT | TDOC | |
|---|---|---|
Market Cap | $45.70B | $1.01B |
Volume | 1,964,621 | 4,668,477 |
Sector | Basic Materials | Health |
52-Week High | $78.74 | $9.72 |
52-Week Low | $36.91 | $4.47 |
Typical Hold Time | 36 Days | 39 Days |
Enterprise Value | $55.27B | $1.27B |
Dividend Yield | 0.98% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ArcelorMittal (MT) trades at $64.11, up 2.87% with mixed technical signals showing bearish moving averages but bullish oscillators. The company reported Q2 2026 earnings miss but maintains strong cash flow and operational momentum. Recent news highlights challenges from Ukraine plant disruptions with a $1 billion impairment charge, though strategic expansions and Microsoft partnership provide growth catalysts. Valuation remains attractive with P/S of 0.75 and P/B of 0.84.
Outlook remains cautiously optimistic with analyst consensus price target of $74.33 offering 16% upside. Key risks include geopolitical exposure in Ukraine, volatile steel demand, and elevated capital expenditures. The stock presents value opportunity given discounted valuations against sector peers, supported by improving European order books and shareholder returns through dividends.
Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.
While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
